* 默克公司MRK.NHPV疫苗在中国的代理销售商--中国智飞生物300122.SZ周四早盘大涨7.8%，创三个月新高。
* 智飞生物近期公告称，26价肺炎球菌结合疫苗于澳大利亚启动Ⅰ期临床试验。
* 智飞生物今年迄今仍跌16.9%，同期沪深300指数.CSI300上扬4.7%。（完）
更多股市简讯请点选CN-CMN-HOT
(发稿 刘珞焱；审校 林高丽)
((luoyan.liu@tr.com; +86 021 2083 0166;))
* 默克公司MRK.NHPV疫苗在中国的代理销售商--中国智飞生物300122.SZ周四早盘大涨7.8%，创三个月新高。
* 智飞生物近期公告称，26价肺炎球菌结合疫苗于澳大利亚启动Ⅰ期临床试验。
* 智飞生物今年迄今仍跌16.9%，同期沪深300指数.CSI300上扬4.7%。（完）
更多股市简讯请点选CN-CMN-HOT
(发稿 刘珞焱；审校 林高丽)
((luoyan.liu@tr.com; +86 021 2083 0166;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.